BACKGROUND Chronic insomnia affects about 6%-13% of the Canadian population.Although treatments already exist,they each have their own issues.Neurofeedback is a neuromodulation technique that specifically targets abno...
The work related to this review was partially supported by Duke University Fund.
Programmed cell death protein 1(PD-1)is an immune checkpoint modulator and a major target of immunotherapy as anti-PD-1 monoclonal antibodies have demonstrated remarkable efficacy in cancer treatment.Accumulating evid...
Background: Chronic headache following traumatic brain injury(TBI) sustained in military service, while common, is highly challenging to treat with existing pharmacologic and non-pharmacologic interventions, and it ma...